VISN Coag CPRR Per Station FINAL.xlsx
XLSX spreadsheet 34 KB Posted
- Solicitation number
- 36C25925Q0074
About this file
This file is a detailed quantity estimation spreadsheet showing coagulation testing requirements across multiple VA medical facilities within VISN 19 over a base year and four option years. The spreadsheet breaks down estimated quantities for various coagulation tests including Prothrombin Time (PT), Partial Thromboplastin Time (PTT), D-Dimer, Fibrinogen, and other specialized coagulation tests for facilities in Fort Harrison, Billings, Cheyenne, Denver, Grand Junction, Muskogee, Tulsa, Oklahoma, Lawton, Salt Lake City, and Sheridan.
The largest volume requirements are at facilities like Salt Lake City (84,750 PT tests total), Oklahoma City (83,500 PT tests total), and Denver (26,839 PT tests total). The spreadsheet details both routine tests like PT/PTT as well as specialized tests such as Anti-factor Xa, HIT testing, and Von Willebrand testing, though many specialized tests show zero quantities at most locations. Denver appears to have the most comprehensive testing menu, requiring nearly all test types listed. This document appears to support a broader solicitation (36C25925Q0074) for a Blanket Purchase Agreement for coagulation testing equipment and supplies.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| SCHEDULE.xlsx | XLSX spreadsheet | |
| DELIVERY.xlsx | XLSX spreadsheet | |
| 36C25925Q0074 0002.docx | DOCX document | |
| 36C25925Q0074 0001.docx | DOCX document | |
| MDS2-Worksheet.xlsx | XLSX spreadsheet | |
| 36C25925Q0074.docx | DOCX document | |
| VA Directive 6550 App A Fillable.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
436 Fort Harrison
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 3200 | 3200 | 3200 | 3200 | 3200 | 16000 |
| Partial Thromboplastin Time (PTT) | 1600 | 1600 | 1600 | 1600 | 1600 | 8000 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 12 | 12 | 12 | 12 | 12 | 60 |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 272 | 272 | 272 | 272 | 272 | 1360 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
436 Billings
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 1200 | 1200 | 1200 | 1200 | 1200 | 6000 |
| Partial Thromboplastin Time (PTT) | 144 | 144 | 144 | 144 | 144 | 720 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 0 | 0 | 0 | 0 | 0 | |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 12 | 12 | 12 | 12 | 12 | 60 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
442 Cheyenne
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 3756 | 4000 | 4000 | 4000 | 4000 | 19756 |
| Partial Thromboplastin Time (PTT) | 1712 | 1800 | 1800 | 1800 | 1800 | 8912 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 0 | 0 | 0 | 0 | 0 | |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 800 | 850 | 900 | 900 | 900 | 4350 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 100 | 125 | 150 | 150 | 150 | 675 |
| HIT Heparin Induced Thrombocytopenia | 100 | 100 | 100 | 100 | 100 | 500 |
554 Denver
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 4900 | 5145 | 5402 | 5557 | 5835 | 26839 |
| Partial Thromboplastin Time (PTT) | 14800 | 15540 | 16317 | 17133 | 17990 | 81780 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 750 | 788 | 827 | 869 | 913 | 4147 |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | 0 |
| Anti-Thrombin III (ATIII) | 60 | 13 | 14 | 15 | 16 | 118 |
| D-Dimer | 2700 | 2835 | 2977 | 3126 | 3283 | 14921 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | 0 |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | 0 |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | 0 |
| Protein C Activity | 35 | 37 | 39 | 41 | 43 | 195 |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | 0 |
| Protein S Free Antigen | 50 | 53 | 56 | 59 | 62 | 280 |
| Activated Protein C Resistance | 50 | 53 | 56 | 59 | 62 | 280 |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time and Lupus Anticoagulant Test | 155 | 163 | 171 | 180 | 189 | 858 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| Factor Assay VIII | 8 | 9 | 10 | 11 | 12 | 50 |
| Factor Assay IX | 10 | 11 | 12 | 13 | 14 | 60 |
| Factor X Assay | 12 | 13 | 14 | 15 | 16 | 70 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Activity | 30 | 32 | 33 | 34 | 35 | 164 |
| Von Willebrand Antigen | 20 | 21 | 22 | 23 | 24 | 110 |
| Anti-factor Xa | 1550 | 1628 | 1709 | 1795 | 1885 | 8567 |
| HIT Heparin Induced Thrombocytopenia | 45 | 47 | 50 | 53 | 56 | 251 |
575 Grand Junction
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 3000 | 3030 | 3060 | 3100 | 3130 | 15320 |
| Partial Thromboplastin Time (PTT) | 250 | 275 | 300 | 330 | 360 | 1515 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 0 | 0 | 0 | 0 | 0 | |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 500 | 510 | 520 | 530 | 540 | 2600 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 30 | 35 | 40 | 40 | 40 | 185 |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
623 Muskogee
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 7200 | 7200 | 7200 | 7200 | 7200 | 36000 |
| Partial Thromboplastin Time (PTT) | 5100 | 5100 | 5100 | 5100 | 5100 | 25500 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 0 | 0 | 0 | 0 | 0 | |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 0 | 0 | 0 | 0 | 0 | |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
623 Tulsa
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 2268 | 2496 | 2748 | 3024 | 3324 | 13860 |
| Partial Thromboplastin Time (PTT) | 120 | 132 | 144 | 156 | 168 | 720 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 0 | 0 | 0 | 0 | 0 | |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 0 | 0 | 0 | 0 | 0 | |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
635 Oklahoma
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 13600 | 15000 | 16600 | 18300 | 20000 | 83500 |
| Partial Thromboplastin Time (PTT) | 13000 | 14300 | 15730 | 17300 | 19030 | 79360 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 360 | 390 | 395 | 435 | 480 | 2060 |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 1000 | 1010 | 1210 | 1330 | 1460 | 6010 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
635 Lawton
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 250 | 204 | 229 | 215 | 234 | 1132 |
| Partial Thromboplastin Time (PTT) | 0 | 0 | 0 | 0 | 0 | |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 0 | 0 | 0 | 0 | 0 | |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 0 | 0 | 0 | 0 | 0 | |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
660 Salt Lake City
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 16950 | 16950 | 16950 | 16950 | 16950 | 84750 |
| Partial Thromboplastin Time (PTT) | 9609 | 9609 | 9609 | 9609 | 9609 | 48045 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 1202 | 1202 | 1202 | 1202 | 1202 | 6010 |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 1500 | 1500 | 1500 | 1500 | 1500 | 7500 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
666 Sheridan
| Test Name | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | TOTAL |
| Prothrombin Time (PT) | 665 | 670 | 675 | 680 | 685 | 3375 |
| Partial Thromboplastin Time (PTT) | 130 | 135 | 140 | 145 | 150 | 700 |
| Reagents By the Box | Base Year Estimated Qty. | OY1 Estimated Qty. | OY2 Estimated Qty. | OY3 Estimated Qty. | OY4 Estimated Qty. | |
| Fibrinogen (FBG) | 0 | 0 | 0 | 0 | 0 | |
| Thrombin Time (TT) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin III (ATIII) | 0 | 0 | 0 | 0 | 0 | |
| D-Dimer | 100 | 105 | 110 | 115 | 120 | 550 |
| Heparin Assay (covered under Anti-Factor XA) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Activity (Covered under Anti-Thrombin III) | 0 | 0 | 0 | 0 | 0 | |
| Anti-Thrombin Antigen | 0 | 0 | 0 | 0 | 0 | |
| Protein C Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Activity | 0 | 0 | 0 | 0 | 0 | |
| Protein S Free Antigen | 0 | 0 | 0 | 0 | 0 | |
| Activated Protein C Resistance | 0 | 0 | 0 | 0 | 0 | |
| Lupus Antocoagulant testing: Dilute Russell Viper Venom Time | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Lupus Antocoagulant testing: Lupus Anticoagulant Test | 0 | 0 | 0 | 0 | 0 | |
| Factor Assays (II through XII) | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | 0 | ||
| Von Willebrand Activity | 0 | 0 | 0 | 0 | 0 | |
| Von Willebrand Antigen | 0 | 0 | 0 | 0 | 0 | |
| Anti-factor Xa | 0 | 0 | 0 | 0 | 0 | |
| HIT Heparin Induced Thrombocytopenia | 0 | 0 | 0 | 0 | 0 |
File details come from the government source that posted it. Updated .